Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Signs Comarketing, Research Agreements for Mass Spec Applications

NEW YORK – Thermo Fisher Scientific on Monday announced two comarketing agreements and a research collaboration involving its mass spectrometry, sample preparation, and analysis software technologies.

Under a comarketing agreement with Berkeley, California-based Newomics, the companies will combine Thermo Fisher's LC-MS systems with the Newomics Microflow-nanospray Electrospray Ionization, or MnESI,?source to analyze bioorganic complexes with high sensitivity and throughput while maintaining their native state. This could have applications for targeted peptide quantification and for the analysis of intact native and denatured proteins. The deal follows a 2019 comarketing agreement between the firms.

Thermo Fisher also signed an agreement with Advanced Electrophoresis Solutions, based in Ontario, Canada, under which the firms will jointly promote Thermo Fisher's expertise in mass spectrometry for biopharma and proteomics applications and AES' whole-column imaging detection capillary electrophoresis systems for protein separation, quantification, and characterization.

Separately, Thermo Fisher has teamed up with researchers at the University of Sheffield in the UK to develop workflows for the characterization and monitoring of complex oligonucleotide and mRNA products. The collaboration will bring together the university's research expertise in this area with Thermo Fisher's magnetic bead technology for sample preparation, liquid chromatography technology, mass spectrometers, and software.

Financial terms of the three agreements were not disclosed.

The Scan

First Foreign Ties Trial

A Tennessee researcher is to go on trial for allegedly making false claims about his ties to a research institution in China, the Wall Street Journal reports.

What Good Puppies!

Dogs have been bred to understand people from a young age, according to New Scientist.

Sneaks Past the System at First

The New York Times writes that a new study gives insight into how the Alpha variant of SARS-CoV-2 may be more transmissible.

PLOS Papers on Adverse Drug Reaction GWAS, Rare Variant Gene Regulators, Ovarian Cancer MicroRNAs

In PLOS this week: genome-wide association study of adverse drug reactions, new approach to identify variants affecting gene expression regulation, and more.
123